{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:16:11Z","timestamp":1788617771247,"version":"build-2803163510"},"reference-count":56,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.1248\/bpb.b25-00313","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:08:20Z","timestamp":1764281300000},"page":"1813-1821","source":"Crossref","is-referenced-by-count":1,"title":["Propofol Alleviates LPS-Induced Acute Lung Injury by Inhibiting Pulmonary Alveolar Epithelium Pyroptosis"],"prefix":"10.1248","volume":"48","author":[{"given":"Xianhuan","family":"Zhang","sequence":"first","affiliation":[{"name":"General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group, Fushun 113000, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Tian","sequence":"additional","affiliation":[{"name":"General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group, Fushun 113000, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Guangzhou Development District Hospital, Huangpu District, Guangzhou 510730, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch. Pathol. Lab. Med.<\/i>, 140<\/b>, 345\u2013350 (2016).","DOI":"10.5858\/arpa.2015-0519-RA"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) de Souza Xavier Costa N, da Costa Sigrist G, Schalch AS, Belotti L, Dolhnikoff M, da Silva LFF. Lung tissue expression of epithelial injury markers is associated with acute lung injury severity but does not discriminate sepsis from ARDS. Respir. Res.<\/i>, 25<\/b>, 129 (2024).","DOI":"10.1186\/s12931-024-02761-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hoegl S, Burns N, Angulo M, Francis D, Osborne CM, Mills TW, Blackburn MR, Eltzschig HK, Vohwinkel CU. Capturing the multifactorial nature of ARDS\u2014two-hit approach to model murine acute lung injury. Physiol. Rep.<\/i>, 6<\/b>, e13648 (2018).","DOI":"10.14814\/phy2.13648"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ijaz M, Adrish M. Outcomes in patients with acute lung injury\/ARDS vs<\/i>. cardiogenic pulmonary edema. Chest<\/i>, 148<\/b>, e194 (2015).","DOI":"10.1378\/chest.14-3052"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chen Y, Gu Y, Gao Z. Baicalin alleviates LPS-induced cytotoxicity in acute lung injury through mediating METTL14\/SOX6 axis. Shock<\/i>, 63<\/b>, 566\u2013572 (2025).","DOI":"10.1097\/SHK.0000000000002518"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Ziaka M, Exadaktylos A. ARDS associated acute brain injury: from the lung to the brain. Eur. J. Med. Res.<\/i>, 27<\/b>, 150 (2022).","DOI":"10.1186\/s40001-022-00780-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lane T, Sottile PD, Peterson R, Jin Y, Moss M. Significant variability in surrogate informed consent rates in ARDS and prevention and early treatment of acute lung injury network multicenter trials. Chest<\/i>, 161<\/b>, 1306\u20131309 (2022).","DOI":"10.1016\/j.chest.2021.09.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Stenlo M, Hyllen S, Silva IAN, Bolukbas DA, Pierre L, Hallgren O, Wagner DE, Lindstedt S. Increased particle flow rate from airways precedes clinical signs of ARDS in a porcine model of LPS - induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, 318<\/b>, L510\u2013L517 (2020).","DOI":"10.1152\/ajplung.00524.2019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jagtap J, Audi S, Razeghi-Kondelaji MH, Fish BL, Hansen C, Narayan J, Gao F, Sharma G, Parchur AK, Banerjee A, Bergom C, Medhora M, Joshi A. A rapid dynamic in vivo<\/i> near-infrared fluorescence imaging assay to track lung vascular permeability after acute radiation injury. Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, 320<\/b>, L436\u2013L450 (2021).","DOI":"10.1152\/ajplung.00066.2020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Silver L, Kaplan D, Asencio J, Mandell I, Fishbein J, Shah S. Interrater reliability of the 2015 pediatric acute lung injury consensus conference criteria for pediatric ARDS. Chest<\/i>, 164<\/b>, 650\u2013655 (2023).","DOI":"10.1016\/j.chest.2023.04.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kuzmin B, Wacker M, Ponomarenko J, Movsisyan A, Praetsch F, Marsch G, Keyser O, Fadel M, Scherner M, Wippermann J. Anticoagulation management during veno-venous ECMO support because of ARDS: single-center experience. Heliyon<\/i>, 10<\/b>, e40417 (2024).","DOI":"10.1016\/j.heliyon.2024.e40417"},{"key":"12","unstructured":"12) Issaris V, Milas GP, Dragonas CG, Poupouzas G, Anagnostopoulos N, Rovina N. The dead space fraction as a prognostic death indicator in patients with ARDS: a systematic review and meta-analysis. Eur. Rev. Med. Pharmacol. Sci.<\/i>, 28<\/b>, 4561\u20134575 (2024)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gao R, Lin PH, Fang ZY, Yang WJ, Gao WY, Wang FQ, Pan XW, Yu WY. Cell-derived biomimetic nanoparticles for the targeted therapy of ALI\/ARDS. Drug Deliv. Transl. Res.<\/i>, 14<\/b>, 1432\u20131457 (2024).","DOI":"10.1007\/s13346-023-01494-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Liang D, Liu C, Yang M. Mesenchymal stem cells and their derived exosomes for ALI\/ARDS: a promising therapy. Heliyon<\/i>, 9<\/b>, e20387 (2023).","DOI":"10.1016\/j.heliyon.2023.e20387"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Liu C, Xiao K, Xie L. Advances in the use of exosomes for the treatment of ALI\/ARDS. Front. Immunol.<\/i>, 13<\/b>, 971189 (2022).","DOI":"10.3389\/fimmu.2022.971189"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Wang Z, Yu T, Hou Y, Zhou W, Ding Y, Nie H. Mesenchymal stem cell therapy for ALI\/ARDS: therapeutic potential and challenges. Curr. Pharm. Des.<\/i>, 28<\/b>, 2234\u20132240 (2022).","DOI":"10.2174\/1381612828666220707104356"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang S, Tang Z, Zheng X, Deng J, Wang Z. Efficacy of human immunoglobulin injection and effects on serum inflammatory cytokines in neonates with acute lung injury. Exp. Ther. Med.<\/i>, 22<\/b>, 931 (2021).","DOI":"10.3892\/etm.2021.10363"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Khalighi Z, Rahmani A, Cheraghi J, Ahmadi MR, Soleimannejad K, Asadollahi R, Asadollahi K. Perfluorocarbon attenuates inflammatory cytokines, oxidative stress and histopathologic changes in paraquat-induced acute lung injury in rats. Environ. Toxicol. Pharmacol.<\/i>, 42<\/b>, 9\u201315 (2016).","DOI":"10.1016\/j.etap.2015.12.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ji C, Hao X, Li Z, Liu J, Yan H, Ma K, Li L, Zhang L. Phillyrin prevents sepsis-induced acute lung injury through inhibiting the NLRP3\/caspase-1\/GSDMD-dependent pyroptosis signaling pathway. Acta Biochim. Biophys. Sin. (Shanghai)<\/i>, 57<\/b>, 447\u2013462 (2025).","DOI":"10.3724\/abbs.2024161"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Shen X, He L, Cai W. Role of lipopolysaccharides in the inflammation and pyroptosis of alveolar epithelial cells in acute lung injury and acute respiratory distress syndrome. J. Inflamm. Res.<\/i>, 17<\/b>, 5855\u20135869 (2024).","DOI":"10.2147\/JIR.S479051"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shen Y, He Y, Pan Y, Liu L, Liu Y, Jia J. Role and mechanisms of autophagy, ferroptosis, and pyroptosis in sepsis-induced acute lung injury. Front. Pharmacol.<\/i>, 15<\/b>, 1415145 (2024).","DOI":"10.3389\/fphar.2024.1415145"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Huang D, Song X, Luo Z, Zou K. Research progress and hotspot evolution of ferroptosis and pyroptosis in acute lung injury and acute respiratory distress syndrome over the past decade. Asian J. Surg.<\/i>, 47<\/b>, 4167\u20134168 (2024).","DOI":"10.1016\/j.asjsur.2024.05.087"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Peng Y, Yang Y, Li Y, Shi T, Xu N, Liu R, Luan Y, Yao Y, Yin C. Mitochondrial (mt)DNA-cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling promotes pyroptosis of macrophages via<\/i> interferon regulatory factor (IRF)7\/IRF3 activation to aggravate lung injury during severe acute pancreatitis. Cell. Mol. Biol. Lett.<\/i>, 29<\/b>, 61 (2024).","DOI":"10.1186\/s11658-024-00575-9"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yu X, Li C. Protective effects of propofol on experimental neonatal acute lung injury. Mol. Med. Rep.<\/i>, 19<\/b>, 4507\u20134513 (2019).","DOI":"10.3892\/mmr.2019.10113"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Takouda J, Nakamura M, Murasaki A, Shimosako W, Hidaka A, Honda S, Tanimura S, Ishibashi F, Kawasaki N, Ishihara J, Fukuda T, Takeda K. Identification of Azalamellarin N as a pyroptosis inhibitor. Biol. Pharm. Bull.<\/i>, 47<\/b>, 28\u201336 (2024).","DOI":"10.1248\/bpb.b23-00569"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Zhang Z, Chen H, Han L, Liu K, Du S, Gao R. Inhibition of the NLRP3\/caspase-1 cascade related pyroptosis relieved propofol-induced neuroinflammation and cognitive impairment in developing rats. Free Radic. Biol. Med.<\/i>, 225<\/b>, 87\u201397 (2024).","DOI":"10.1016\/j.freeradbiomed.2024.09.038"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Kan H, Zhao M, Wang W, Sun B. Understanding propofol\u2019s protective mechanism in tubular epithelial cells: mitigating pyroptosis via<\/i> the miR-143-3p\/ATPase Na+<\/sup>\/K+<\/sup> transporting subunit alpha 2 pathway in renal ischemia-reperfusion. Mol. Biotechnol.<\/i>, 67<\/b>, 1165\u20131177 (2025).","DOI":"10.1007\/s12033-024-01116-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Liu Z, Meng Y, Miao Y, Yu L, Yu Q. Propofol reduces renal ischemia\/reperfusion-induced acute lung injury by stimulating sirtuin 1 and inhibiting pyroptosis. Aging<\/i>, 13<\/b>, 865\u2013876 (2021).","DOI":"10.18632\/aging.202191"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tomita K, Nakashima KI, Yamaguchi E, Itoh A, Inoue M. Dual Anti-inflammatory actions of a novel retinoid X receptor agonist derived from a natural compound in microglial cells. Biol. Pharm. Bull.<\/i>, 48<\/b>, 440\u2013449 (2025).","DOI":"10.1248\/bpb.b25-00037"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Zhou H, Jiang F, Leng Y. Propofol ameliorates ox-LDL-induced endothelial damage through enhancing autophagy via<\/i> PI3K\/Akt\/m-TOR pathway: a novel therapeutic strategy in atherosclerosis. Front. Mol. Biosci.<\/i>, 8<\/b>, 695336 (2021).","DOI":"10.3389\/fmolb.2021.695336"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chang CY, Chen PH, Lu SC, Hsieh MC, Lin CW, Lee HM, Jawan B, Kao YH. Propofol-enhanced autophagy increases motility and angiogenic capacity of cultured human umbilical vascular endothelial cells. Life Sci.<\/i>, 142<\/b>, 49\u201359 (2015).","DOI":"10.1016\/j.lfs.2015.10.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Bredthauer A, Geiger A, Gruber M, Pfaehler SM, Petermichl W, Bitzinger D, Metterlein T, Seyfried T. Propofol ameliorates exaggerated human neutrophil activation in a LPS sepsis model. J. Inflamm. Res.<\/i>, 14<\/b>, 3849\u20133862 (2021).","DOI":"10.2147\/JIR.S314192"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Ghasemi M, Turnbull T, Sebastian S, Kempson I. The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int. J. Mol. Sci.<\/i>, 22<\/b>, 12827 (2021).","DOI":"10.3390\/ijms222312827"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Zou Y, Kim D, Yagi M, Yamasaki Y, Kurita J, Iida T, Matsuyama Y, Yamaguchi K, Oda T. Application of LDH-release assay to cellular-level evaluation of the toxic potential of harmful algal species. Biosci. Biotechnol. Biochem.<\/i>, 77<\/b>, 345\u2013352 (2013).","DOI":"10.1271\/bbb.120764"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Zhao W, Zhou S, Yao W, Gan X, Su G, Yuan D, Hei Z. Propofol prevents lung injury after intestinal ischemia-reperfusion by inhibiting the interaction between mast cell activation and oxidative stress. Life Sci.<\/i>, 108<\/b>, 80\u201387 (2014).","DOI":"10.1016\/j.lfs.2014.05.009"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Cheng KT, Xiong S, Ye Z, Hong Z, Di A, Tsang KM, Gao X, An S, Mittal M, Vogel SM, Miao EA, Rehman J, Malik AB. Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury. J. Clin. Invest.<\/i>, 127<\/b>, 4124\u20134135 (2017).","DOI":"10.1172\/JCI94495"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wang X, Liu C, Wang G. Propofol protects rats and human alveolar epithelial cells against lipopolysaccharide-induced acute lung injury via<\/i> inhibiting hmgb1 expression. Inflammation<\/i>, 39<\/b>, 1004\u20131016 (2016).","DOI":"10.1007\/s10753-016-0330-6"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Lv X, Zhou X, Yan J, Jiang J, Jiang H. Propofol inhibits lps-induced apoptosis in lung epithelial cell line, beas-2b. Biomed. Pharmacother.<\/i>, 87<\/b>, 180\u2013187 (2017).","DOI":"10.1016\/j.biopha.2016.12.074"},{"key":"39","unstructured":"39) Wang M, Zhu Y, Zhao H, Zhao HF. Moxibustion intervention improves synovitis by down-regulating NLRP3\/Caspase-1\/IL-1beta signaling of synovial tissue in rats with adjuvant arthritis. Zhen Ci Yan Jiu<\/i>, 48<\/b>, 1111\u20131116 (2023)."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Zheng Y, Zhu T, Chen B, Fang Y, Wu Y, Feng X, Pang M, Wang H, Zhu J, Lin Z. Diallyl disulfide attenuates pyroptosis via<\/i> nlrp3\/caspase-1\/il-1beta signaling pathway to exert a protective effect on hypoxic-ischemic brain damage in neonatal rats. Int. Immunopharmacol.<\/i>, 124<\/b> (Pt. B), 111030 (2023).","DOI":"10.1016\/j.intimp.2023.111030"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Qiao S, Zhang X, Chen Z, Zhao Y, Tzeng CM. Alloferon-1 ameliorates estrogen deficiency-induced osteoporosis through dampening the NLRP3\/Caspase-1\/IL-1beta\/IL-18 signaling pathway. Int. Immunopharmacol.<\/i>, 124<\/b>(Pt. B), 110954 (2023).","DOI":"10.1016\/j.intimp.2023.110954"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Chen L, Hou W, Liu F, Zhu R, Lv A, Quan W, Mao S. Blockade of NLRP3\/Caspase-1\/IL-1beta regulated Th17\/Treg immune imbalance and attenuated the neutrophilic airway inflammation in an ovalbumin-induced murine model of asthma. J. Immunol. Res.<\/i>, 2022<\/b>, 9444227 (2022).","DOI":"10.1155\/2022\/9444227"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Fang R, Du H, Lei G, Liu Y, Feng S, Ye C, Li N, Peng Y. NLRP3 inflammasome plays an important role in caspase-1 activation and IL-1beta secretion in macrophages infected with pasteurella multocida. Vet. Microbiol.<\/i>, 231<\/b>, 207\u2013213 (2019).","DOI":"10.1016\/j.vetmic.2019.03.019"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Zha C, Qi Y, Xing F, Li J. Astragaloside IV inhibits the pyroptosis in the acute kidney injury through targeting the SIRT1\/FOXO3a axis. Chem. Pharm. Bull.<\/i>, 72<\/b>, 923\u2013931 (2024).","DOI":"10.1248\/cpb.c24-00151"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Cao J, Bao Q, Hao H. Indole-3-carboxaldehyde alleviates LPS-induced intestinal inflammation by inhibiting ROS production and NLRP3 inflammasome activation. Antioxid.<\/i>, 13<\/b>, 1107 (2024).","DOI":"10.3390\/antiox13091107"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Zeng HB, Zhang LH, Yuan DP, Wang W, Su XM, Weng WX, Miao R, Xu JY, Long J, Song YH. Methylophiopogonanone a inhibits LPS\/ATP-induced macrophage pyroptosis via<\/i> ROS\/NLRP3 pathway. Mol. Biol.<\/i>, 57<\/b>, 106\u2013108 (2023).","DOI":"10.31857\/S0026898423010196"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Huang T, Zhang Y, Wang C, Gao J. Propofol reduces acute lung injury by up-regulating gamma-aminobutyric acid type a receptors. Exp. Mol. Pathol.<\/i>, 110<\/b>, 104295 (2019).","DOI":"10.1016\/j.yexmp.2019.104295"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Han J, Tao W, Cui W, Chen J. Propofol via<\/i> antioxidant property attenuated hypoxia-mediated mitochondrial dynamic imbalance and malfunction in primary rat hippocampal neurons. Oxid. Med. Cell. Longev.<\/i>, 2022<\/b>, 6298786 (2022).","DOI":"10.1155\/2022\/6298786"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Yang C, Xia Z, Li T, Chen Y, Zhao M, Sun Y, Ma J, Wu Y, Wang X, Wang P, Wang H. Antioxidant effect of propofol in gliomas and its association with divalent metal transporter 1. Front. Oncol.<\/i>, 10<\/b>, 590931 (2020).","DOI":"10.3389\/fonc.2020.590931"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Xu J, Xu S, Luo J, Zhang S, Wu D, Yang Q, Fang R, Shi C, Liu Q, Zhao J. Epigallocatechin-3-gallate alleviates ethanol-induced endothelia cells injury partly through alteration of NF-kappaB translocation and activation of the Nrf2 signaling pathway. Biol. Pharm. Bull.<\/i>, 47<\/b>, 1248\u20131254 (2024).","DOI":"10.1248\/bpb.b23-00773"},{"key":"51","unstructured":"51) Ye\u011finsu A, Ergin M. Determination of optimal drying period in wet to dry weight ratio measurement. Tuberk. Toraks.<\/i>, 58<\/b>, 229\u2013230 (2010)."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Guan S, Sun L, Wang X, Huang X, Luo T. Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro<\/i> and in vivo<\/i>. Front. Pharmacol.<\/i>, 14<\/b>, 1161810 (2023).","DOI":"10.3389\/fphar.2023.1161810"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Fan GB, Li Y, Xu GS, Zhao AY, Jin HJ, Sun SQ, Qi SH. Propofol inhibits ferroptotic cell death through the Nrf2\/Gpx4 signaling pathway in the mouse model of cerebral ischemia-reperfusion injury. Neurochem. Res.<\/i>, 48<\/b>, 956\u2013966 (2023).","DOI":"10.1007\/s11064-022-03822-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Napodano C, Carnazzo V, Basile V, Pocino K, Stefanile A, Gallucci S, Natali P, Basile U, Marino M. NLRP3 inflammasome involvement in heart, liver, and lung diseases-a lesson from cytokine storm syndrome. Int. J. Mol. Sci.<\/i>, 24<\/b>, 16556 (2023).","DOI":"10.3390\/ijms242316556"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Effendi WI, Nagano T. The Crucial role of NLRP3 inflammasome in viral infection-associated fibrosing interstitial lung diseases. Int. J. Mol. Sci.<\/i>, 22<\/b>, 10447 (2021).","DOI":"10.3390\/ijms221910447"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Liu Y, Shang L, Zhou J, Pan G, Zhou F, Yang S. Emodin attenuates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-dependent pyroptosis signaling pathway in vitro<\/i> and in vivo<\/i>. Inflammation<\/i>, 45<\/b>, 753\u2013767 (2022).","DOI":"10.1007\/s10753-021-01581-1"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00313\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:24:19Z","timestamp":1764386659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00313\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00313","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"b25-00313"}}